Top stocks | Open an Account  | Login | Demo
Friday, August 08, 2008
Real news in Real Time! National and international updates on all products by leading agencies such as Dow Jones, Capital Markets, Commodities Control and more.
Equity  |  Derivatives  |  IPO  |  Commodity  |  Mutual Funds  |  Offshore  |  Insurance  |  Gold coins  |  PMS  |  Mobile

OVERVIEW

Capital Market Live News    Dow Jones News Wire    Derivatives/F&O News    Advanced Search   
Commodity News    Offshore News    News Ticker   


Equity News
Jul 26 2008 7:20PM
Ankur Drugs & Pharma net profit rises 139.25% in the June 2008 quarter
Net profit of Ankur Drugs & Pharma rose 139.25% to Rs 21.58 crore in the quarter ended June 2008 as against Rs 9.02 crore during the previous quarter ended June 2007. Sales rose 138.26% to Rs 231.14 crore in the quarter ended June 2008 as against Rs 97.01 crore during the previous quarter ended June 2007.

Powered byCapital Market - Live News
  Source:   

   Capital Market Disclaimer
Back
 
 
News
 
Research
 
Markets
 
Knowledge Center
 
Technical charts
 
Customer Service
 
Branch Locator
 
Careers
 



SEBI | BSE | NSE
Terms & Conditions | Disclaimer | Online Privacy | Trouble Logging in | Glossary | Site Map
Copyright© 2008. All rights Reserved. Reliance Money Limited
Equities: Trading through Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 | BSE SEBI
Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 Commodities : Trading through Reliance Commodities Limited | MCX member code: 29030 | NCDEX member code: NCDEX-CO-05-00647|
NMCE member code: CL0120 Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances please write to [email protected]